Overview

DOSE Trial of Opioid Sparing Effect

Status:
Terminated
Trial end date:
2020-11-06
Target enrollment:
Participant gender:
Summary
Multicenter, double blind randomized controlled trial of fentanyl vs. fentanyl + dexmedetomidine as the initial regimen for maintenance of sedation in mechanically-ventilated, critically ill children. This trial will evaluate the opioid-sparing effect of dexmedetomidine when administered with fentanyl to mechanically ventilated, critically ill children. Study drug or placebo will be administered with fentanyl, which will be titrated to achieve sedation scores consistent with response to light touch. Plasma samples and bedside assessments for pain, sedation, and delirium will be collected.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Collaborators:
Intermountain Health Care, Inc.
Johns Hopkins University
National Institutes of Health (NIH)
Vanderbilt University Medical Center
Treatments:
Dexmedetomidine
Fentanyl